PTC Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Revenue	937.82	698.8	538.59	380.77	306.98	Upgrade
Revenue Growth (YoY)	34.20%	29.75%	41.45%	24.04%	15.96%	Upgrade
Cost of Revenue	65.49	44.68	32.33	18.94	12.14	Upgrade
Gross Profit	872.34	654.12	506.27	361.82	294.85	Upgrade
Selling, General & Admin	332.54	326	285.77	245.16	202.54	Upgrade
Research & Development	666.56	651.5	540.68	477.64	257.45	Upgrade
Other Operating Expenses	440.44	149.94	54.75	47.51	27.65	Upgrade
Operating Expenses	1,440	1,127	881.21	770.31	487.64	Upgrade
Operating Income	-567.2	-473.31	-374.94	-408.49	-192.8	Upgrade
Interest Expense / Income	129.18	90.87	86.02	56.35	12.49	Upgrade
Other Expense / Income	-0.27	23.31	57.38	-61.91	34.64	Upgrade
Pretax Income	-696.11	-587.49	-518.34	-402.93	-239.93	Upgrade
Income Tax	-69.51	-28.47	5.56	35.23	11.65	Upgrade
Net Income	-626.6	-559.02	-523.9	-438.16	-251.58	Upgrade
Shares Outstanding (Basic)	75	72	70	66	59	Upgrade
Shares Outstanding (Diluted)	75	72	70	66	59	Upgrade
Shares Change	4.34%	1.79%	6.72%	12.17%	26.38%	Upgrade
EPS (Basic)	-8.37	-7.79	-7.43	-6.64	-4.27	Upgrade
EPS (Diluted)	-8.37	-7.79	-7.43	-6.64	-4.27	Upgrade
Free Cash Flow	-186.86	-388.67	-279.55	-211.91	-112.4	Upgrade
Free Cash Flow Per Share	-2.50	-5.42	-3.97	-3.21	-1.91	Upgrade
Gross Margin	93.02%	93.61%	94.00%	95.03%	96.05%	Upgrade
Operating Margin	-60.48%	-67.73%	-69.62%	-107.28%	-62.80%	Upgrade
Profit Margin	-66.81%	-80.00%	-97.27%	-115.07%	-81.95%	Upgrade
Free Cash Flow Margin	-19.92%	-55.62%	-51.90%	-55.65%	-36.61%	Upgrade
EBITDA	-320.51	-357.9	-360.8	-255.62	-191.55	Upgrade
EBITDA Margin	-34.18%	-51.22%	-66.99%	-67.13%	-62.40%	Upgrade
Depreciation & Amortization	246.42	138.72	71.52	90.96	35.89	Upgrade
EBIT	-566.93	-496.62	-432.32	-346.58	-227.44	Upgrade
EBIT Margin	-60.45%	-71.07%	-80.27%	-91.02%	-74.09%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).